Get started
Author

Susan A. Cartlidge

Observed name: SUSAN A. CARTLIDGE
OpenAlex ID: A5111444178
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2011 · Jin Gao, Jon W. Chesebrough, et al. · Cancer Research · 122
Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
1987 · Susan A. Cartlidge, Ruth Duncan, et al. · Journal of Controlled Release · 49
Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
1986 · Susan A. Cartlidge, Ruth Duncan, et al. · Journal of Controlled Release · 40
Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
1987 · Susan A. Cartlidge, Ruth Duncan, et al. · Journal of Controlled Release · 36
Substrate selection and processing in endocytosis
1984 · JOHN B. LLOYD, MARGARET K. PRATTEN, et al. · Biochemical Society Transactions · 9
Targeting of soluble cross-linked N-(2-hydroxypropyl)methacrylamide copolymers in vivo. A potential drug delivery system
1984 · SUSAN A. CARTLIDGE, PAVLA REJMANOVÁ, et al. · Biochemical Society Transactions · 6
Data from Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2023 · Jin Gao, Jon W. Chesebrough, et al.
Supplementary Figures 1-4, Tables 1-2 from Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2023 · Jin Gao, Jon W. Chesebrough, et al.
Supplementary Figures 1-4, Tables 1-2 from Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2023 · Jin Gao, Jon W. Chesebrough, et al.
PDF
Data from Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2023 · Jin Gao, Jon W. Chesebrough, et al.
Evaluation of crosslinked soluble N-(2-hydroxypropyl)methacrylamide copolymers as a potential drug carrier
1985 · Susan A. Cartlidge · Keele Research Repository (Keele University)
PDF
Works count: 11
Citation count: 262
H-index: 6
I10-index: 4
Year
Topic
Type